insights_auto
Why is GANX down 4.82%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$1.00
arrow_downward
-4.82%(-0.051) 1D
$1.00
arrow_upward
+0.06% (+0.00060)bedtimeAfter hours
Closed: Nov 20, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.02
High
$1.10
Low
$0.97
Mkt. cap
44.50M
Avg. vol.
690.72K
Volume
586.26K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.02
High
$1.10
Low
$0.97
Mkt. cap
44.50M
Avg. vol.
690.72K
Volume
586.26K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
Traders Union
·
43 minutes ago
A 12% S&P 500 drop matches UK and German markets going to zero, Howard Lindzon notes
Wisevoter
·
18 minutes ago
S&P 500 and Dow Slide Into Correction
Blockonomi
·
1 hour ago
S&P 500 Correction Deepens as Investors Watch for Signs of a Market Bottom
StoneX
·
2 days ago
S&P 500, Nasdaq 100 Drive into Correction Territory
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com